Investing Articles

All Investing Articles

62284 Articles

Rich Duprey | Jul 21, 2026 at 11:31 AM EDT

SK Hynix’s HBM Empire Powers 65% US Revenue — Is This the Must-Own AI Stock?

While investors chase GPU makers, a South Korean chipmaker has quietly locked up the single most critical chokepoint in AI…

Vandita Jadeja | Jul 21, 2026 at 11:30 AM EDT

AMC Stock After Record Earnings: Buy, Sell, or Hold?

AMC just posted the strongest quarter in its 106-year history, and the stock still has Wall Street's consensus pointing the…

David Beren | Jul 21, 2026 at 11:29 AM EDT

4 High-Yield ETFs to Buy When the VIX Spikes in 2026

When the VIX spikes, most income investors reach for the same handful of dividend funds without knowing how differently each…

Michael Williams | Jul 21, 2026 at 11:24 AM EDT

XFUNDS Launches DRMY, a New Semiconductor ETF That Sells Options for Monthly Income

A new ETF just bet that memory chips and options premiums can coexist in one fund, but with 8 to…

David Beren | Jul 21, 2026 at 11:10 AM EDT

The 13.49% Expense Ratio Trap: Why PBDC Still Beats Expectations for Income Investors

A 13.49% expense ratio looks like an automatic disqualifier, but the number that stops investors cold on PBDC's fact sheet…

David Moadel | Jul 21, 2026 at 11:07 AM EDT

Coinbase Surges 11%, Strategy and Hut 8 Gain 5% as Crypto Catalysts Stack Up

A policy vote in Washington, a Bitcoin breakout, and a surprise AI angle are pulling crypto stocks in three different…

Rich Duprey | Jul 21, 2026 at 11:03 AM EDT

Better Late Than Never? Micron Finally Joins Wall Street’s ‘Best Investment Ideas” List

Retail investors rode Micron's AI memory boom to stunning gains while Wall Street analysts were still doing the math. Now…

Vandita Jadeja | Jul 21, 2026 at 11:00 AM EDT

Johnson & Johnson vs Abbott Laboratories: Two Healthcare Giants on Opposite Trajectories

JNJ is pruning its portfolio while Abbott just dropped $21 billion to expand into cancer diagnostics, and the two strategies…

Alex Sirois | Jul 21, 2026 at 10:52 AM EDT

The Cold, Hard Facts About SpaceX’s Value Are Hiding in Plain Sight

Wall Street sees SpaceX doubling from here while one prominent analyst calls it worth half the current price, and the…

Alex Sirois | Jul 21, 2026 at 10:50 AM EDT

Cash is Always King Which is Why I Will Not Stop Adding Broadcom

Wall Street keeps punishing Broadcom while its cash registers keep ringing, and one investor believes the gap between those two…

Joey Frenette | Jul 21, 2026 at 10:45 AM EDT

AMD Prepares for Its Massive ‘Advancing AI’ Summit — Why New Launches Might Help It Challenge Nvidia’s Dominance This Week

AMD's two-day AI summit could jolt a sector that investors are losing their nerve on, but the real story has…

Danielle Liverance | Jul 21, 2026 at 10:45 AM EDT

XRP Holders Have Until July 23 to Find Out if a Key Crypto Bill Survives. Here’s What’s at Stake.

A Senate deadline this Thursday could determine whether XRP gets the permanent legal protection institutional investors have been waiting on,…

Vandita Jadeja | Jul 21, 2026 at 10:45 AM EDT

Price Prediction: Credo Stock Will Trade at This Price in 2027

Credo Technology's revenue tripled and its stock soared over 1,600% in five years, yet shares just cratered 21% in a…

Danielle Liverance | Jul 21, 2026 at 10:43 AM EDT

Bessent: Treasury Department Just Blocked $100 Million in Payments to Dead People. $500 Billion More Is at Stake.

The federal government has been mailing checks to dead people for years, and Treasury Secretary Scott Bessent says a new…

Alex Sirois | Jul 21, 2026 at 10:41 AM EDT

Netflix Fell 45% Over 12 Months But This Ratings House Sees A Doubling Share Price

Netflix has shed nearly half its value while the broader market climbed, yet dozens of Wall Street analysts refuse to…

1 … 23 24 25 26 27 … 667

Investing Articles

All Investing Articles

SK Hynix’s HBM Empire Powers 65% US Revenue — Is This the Must-Own AI Stock?

AMC Stock After Record Earnings: Buy, Sell, or Hold?

4 High-Yield ETFs to Buy When the VIX Spikes in 2026

XFUNDS Launches DRMY, a New Semiconductor ETF That Sells Options for Monthly Income

The 13.49% Expense Ratio Trap: Why PBDC Still Beats Expectations for Income Investors

Coinbase Surges 11%, Strategy and Hut 8 Gain 5% as Crypto Catalysts Stack Up

Better Late Than Never? Micron Finally Joins Wall Street’s ‘Best Investment Ideas” List

Johnson & Johnson vs Abbott Laboratories: Two Healthcare Giants on Opposite Trajectories

The Cold, Hard Facts About SpaceX’s Value Are Hiding in Plain Sight

Cash is Always King Which is Why I Will Not Stop Adding Broadcom

AMD Prepares for Its Massive ‘Advancing AI’ Summit — Why New Launches Might Help It Challenge Nvidia’s Dominance This Week

XRP Holders Have Until July 23 to Find Out if a Key Crypto Bill Survives. Here’s What’s at Stake.

Price Prediction: Credo Stock Will Trade at This Price in 2027

Bessent: Treasury Department Just Blocked $100 Million in Payments to Dead People. $500 Billion More Is at Stake.

Netflix Fell 45% Over 12 Months But This Ratings House Sees A Doubling Share Price

Medicare Advantage Has a 12-Month Trial Period With a Full Escape Hatch. Almost Nobody Uses It in Time.

The Covered Call Tax Trap: These 3 ETFs Pay Around 12 Percent and Legally Shield Most of It From the IRS

Is Equal-Weighting the S&P 500 Worth It? Here’s What the Data Says

Medicare Advantage Has a 12-Month Trial Period With a Full Escape Hatch. Almost Nobody Uses It in Time.

A $550,000 Portfolio That Quietly Pays a 62-Year-Old $3,400 a Month Until Social Security Kicks In

Medicare Advantage Has a 12-Month Trial Period With a Full Escape Hatch. Almost Nobody Uses It in Time.

The Covered Call Tax Trap: These 3 ETFs Pay Around 12 Percent and Legally Shield Most of It From the IRS

Investing Articles

All Investing Articles

SK Hynix’s HBM Empire Powers 65% US Revenue — Is This the Must-Own AI Stock?

AMC Stock After Record Earnings: Buy, Sell, or Hold?

4 High-Yield ETFs to Buy When the VIX Spikes in 2026

XFUNDS Launches DRMY, a New Semiconductor ETF That Sells Options for Monthly Income

The 13.49% Expense Ratio Trap: Why PBDC Still Beats Expectations for Income Investors

Coinbase Surges 11%, Strategy and Hut 8 Gain 5% as Crypto Catalysts Stack Up

Better Late Than Never? Micron Finally Joins Wall Street’s ‘Best Investment Ideas” List

Johnson & Johnson vs Abbott Laboratories: Two Healthcare Giants on Opposite Trajectories

The Cold, Hard Facts About SpaceX’s Value Are Hiding in Plain Sight

Cash is Always King Which is Why I Will Not Stop Adding Broadcom

AMD Prepares for Its Massive ‘Advancing AI’ Summit — Why New Launches Might Help It Challenge Nvidia’s Dominance This Week

XRP Holders Have Until July 23 to Find Out if a Key Crypto Bill Survives. Here’s What’s at Stake.

Price Prediction: Credo Stock Will Trade at This Price in 2027

Bessent: Treasury Department Just Blocked $100 Million in Payments to Dead People. $500 Billion More Is at Stake.

Netflix Fell 45% Over 12 Months But This Ratings House Sees A Doubling Share Price

Medicare Advantage Has a 12-Month Trial Period With a Full Escape Hatch. Almost Nobody Uses It in Time.

The Covered Call Tax Trap: These 3 ETFs Pay Around 12 Percent and Legally Shield Most of It From the IRS

Is Equal-Weighting the S&P 500 Worth It? Here’s What the Data Says

Featured Reads

Medicare Advantage Has a 12-Month Trial Period With a Full Escape Hatch. Almost Nobody Uses It in Time.

A $550,000 Portfolio That Quietly Pays a 62-Year-Old $3,400 a Month Until Social Security Kicks In